Skip to main content
. Author manuscript; available in PMC: 2011 Jul 28.
Published in final edited form as: Arch Dermatol. 2011 May;147(5):540–546. doi: 10.1001/archdermatol.2011.109

Table 4.

Tumors Treated With Mohs Surgery

Patient
Age, y		 Clinical
Subtype or
Descriptor		 Type Additional
Histologic
Features		 Body Location Diameter,
mm		 Training Level
of Treating
Clinician		 Stages,
No.		 Defect
Size Before
Repairs,
mm		 Annual
Visits to
Dermatology
Clinic, Mean No.		 Time After
Treatment to
Detection of
Recurrence, mo
62 Nodular BCC Nodular Lower eyelid, H-zone 8 Attending 2 13 2.0 55
70 Indistinct margins BCC Superficial, nodular Medial canthus, H-zone 7 Attending 3 24 2.6 84
73 Nodular BCC None specified Nasal ala, H-zone 10 Attending 2 18 0.5 50
63 Nodular BCC Superficial, nodular Lower eyelid, H-zone 16 Attending 2 34 0.9 92
65 None specified SCC None specified Nasal sidewall, H-zone 8 Attending 3 10 1.4 105
64a None specified SCC in situ Frontal scalp, H-zone Not specified Attending 1 11 1.3 59

Abbreviations: BCC, basal cell carcinoma; ED&C, electrodessication and curettage; NMSC, nonmelanoma skin cancer; SCC, squamous cell carcinoma.

a

Patient was described in the chart has having human immunodeficiency virus/AIDS.